Pilloxa offers a platform combining smart hardware, phone apps, data visualization and analytics to help patients take medicine and follow treatment guidelines. The product has shown patient adherence above 90% in studies, versus market averages of 60–65%. Major pharmaceutical brands such as Bayer and Sandoz/Novartis are piloting Pilloxa in clinical trials and patient support programs. The company says its real-time data and timely interventions help clinical trials finish faster and reduce research resource use. Pilloxa was founded in 2015 and is based in Stockholm. Following a recent fundraise, the company plans to expand across Europe and scale its customer base.

Total raised

$1M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2019